{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nCytochrome P450 oxidoreductase (POR) is a flavoprotein enzyme that functions as the universal electron donor for all microsomal cytochrome P450 enzymes. By transferring electrons from NADPH to various P450 isoforms, POR underpins a multitude of essential metabolic processes including steroid hormone biosynthesis, drug and xenobiotic metabolism, and even the generation of reactive oxygen species that can trigger ferroptosis. This central role in electron transfer is highlighted by studies demonstrating that POR‐mediated electron leakage can yield hydrogen peroxide, thereby driving polyunsaturated phospholipid peroxidation in cell membranes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its basic catalytic role, POR exhibits dynamic structural properties that modulate its electron transfer efficiency. Detailed biophysical analyses—including nuclear magnetic resonance and small-angle X-ray scattering—demonstrate that conformational flexibility governed by coenzyme binding (via FAD and FMN domains) is critical for coupling electron flow to enzymatic turnover. Such structural transitions not only influence redox kinetics but also ensure proper interfacing with diverse partner cytochrome P450 enzymes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nClinically, mutations and polymorphisms in the POR gene have been linked to a broad spectrum of human disorders. Variants that perturb cofactor binding or alter the protein’s conformation can differentially impair the activities of steroidogenic P450 enzymes—such as CYP17A1, CYP21A2, and CYP19A1—thereby contributing to congenital adrenal hyperplasia and syndromic presentations like Antley-Bixler malformation. Such studies underscore the importance of POR in maintaining endocrine homeostasis and illustrate how specific mutations (e.g., those affecting FMN binding) result in variable clinical phenotypes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nPOR variability also plays a pivotal role in drug metabolism. Genetic polymorphisms, such as the common A503V variant, can modulate the electron transfer efficiency required to support the catalytic activity of cytochrome P450 enzymes like CYP3A4, CYP2C19, and CYP2C9. These differences translate into significant interindividual variations in the pharmacokinetics of clinically important drugs—including immunosuppressants like tacrolimus and various substrates used in probe assays—highlighting POR as a key determinant of drug response and toxicity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurthermore, integrative computational and biochemical analyses have deepened our understanding of the structure–function relationships that govern POR activity. By correlating mutational impacts with changes in key cofactor binding regions and electron transfer interfaces, researchers have revealed mechanistic insights that explain how POR deficiency can act as a modifier in both endocrine disorders and variations in hepatic drug metabolism. These findings also implicate POR as a potential target for therapeutic modulation, particularly in conditions where altered redox homeostasis contributes to disease."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "27"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Bo Yan, Youwei Ai, Qi Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Membrane Damage during Ferroptosis Is Caused by Oxidation of Phospholipids Catalyzed by the Oxidoreductases POR and CYB5R1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2020.11.024"}], "href": "https://doi.org/10.1016/j.molcel.2020.11.024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33321093"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33321093"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Amit V Pandey, Christa E Flück "}, {"type": "b", "children": [{"type": "t", "text": "NADPH P450 oxidoreductase: structure, function, and pathology of diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacol Ther (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.pharmthera.2013.01.010"}], "href": "https://doi.org/10.1016/j.pharmthera.2013.01.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23353702"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23353702"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Ningwu Huang, Vishal Agrawal, Kathleen M Giacomini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0711621105"}], "href": "https://doi.org/10.1073/pnas.0711621105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18230729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18230729"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Steven N Hart, Shuang Wang, Kaori Nakamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e3282f2f121"}], "href": "https://doi.org/10.1097/FPC.0b013e3282f2f121"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18216718"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18216718"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Alexey A Efanov, Alina V Brenner, Tetiana I Bogdanova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Natl Cancer Inst (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jnci/djx209"}], "href": "https://doi.org/10.1093/jnci/djx209"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29165687"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29165687"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Izumi Yanatori, Des R Richardson, Shinya Toyokuni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1/cytochrome P450 reductase complex for heme catabolism and iron transfer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M117.776021"}], "href": "https://doi.org/10.1074/jbc.M117.776021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28655775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28655775"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Wiebke Arlt, Elizabeth A Walker, Nicole Draper, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lancet (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0140-6736(04)16503-3"}], "href": "https://doi.org/10.1016/S0140-6736(04"}, {"type": "t", "text": "16503-3) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15220035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15220035"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Vishal Agrawal, Ningwu Huang, Walter L Miller "}, {"type": "b", "children": [{"type": "t", "text": "Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e32830054ac"}], "href": "https://doi.org/10.1097/FPC.0b013e32830054ac"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18551037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18551037"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Amit V Pandey, Petra Kempná, Gaby Hofer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2007-0245"}], "href": "https://doi.org/10.1210/me.2007-0245"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17595315"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17595315"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Taninee Sahakitrungruang, Ningwu Huang, Meng Kian Tee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2009-1460"}], "href": "https://doi.org/10.1210/jc.2009-1460"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19837910"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19837910"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Christa E Flück, Catherine Nicolo, Amit V Pandey "}, {"type": "b", "children": [{"type": "t", "text": "Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Fundam Clin Pharmacol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1472-8206.2007.00520.x"}], "href": "https://doi.org/10.1111/j.1472-8206.2007.00520.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17635179"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17635179"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Christopher C Marohnic, Satya P Panda, Pavel Martásek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M607095200"}], "href": "https://doi.org/10.1074/jbc.M607095200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16998238"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16998238"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Larissa G Gomes, Ningwu Huang, Vishal Agrawal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2008-0304"}], "href": "https://doi.org/10.1210/jc.2008-0304"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18397975"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18397975"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Hylke de Jonge, Christoph Metalidis, Maarten Naesens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/pgs.11.77"}], "href": "https://doi.org/10.2217/pgs.11.77"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21770725"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21770725"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Ana M Gomes, Stefan Winter, Kathrin Klein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/pgs.09.7"}], "href": "https://doi.org/10.2217/pgs.09.7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19374516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19374516"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Vishal Agrawal, Ji Ha Choi, Kathleen M Giacomini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e32833e0cb5"}], "href": "https://doi.org/10.1097/FPC.0b013e32833e0cb5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20697309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20697309"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Chuan-Jiang Li, Liang Li, Li Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR genetic polymorphisms on tacrolimus metabolism in Chinese renal transplant recipients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0086206"}], "href": "https://doi.org/10.1371/journal.pone.0086206"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24465960"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24465960"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Y Shirasaka, A S Chaudhry, M McDonald, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interindividual variability of CYP2C19-catalyzed drug metabolism due to differences in gene diplotypes and cytochrome P450 oxidoreductase content."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics J (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/tpj.2015.58"}], "href": "https://doi.org/10.1038/tpj.2015.58"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26323597"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26323597"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Dirk R J Kuypers, Henriette de Loor, Maarten Naesens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combined effects of CYP3A5"}, {"type": "i", "children": [{"type": "t", "text": "1, POR*28, and CYP3A4"}]}, {"type": "t", "text": "22 single nucleotide polymorphisms on early concentration-controlled tacrolimus exposure in de-novo renal recipients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0000000000000095"}], "href": "https://doi.org/10.1097/FPC.0000000000000095"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25322286"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25322286"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Aili Zhang, Xin He, Ling Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biogenesis of lysosome-related organelles complex-1 subunit 1 (BLOS1) interacts with sorting nexin 2 and the endosomal sorting complex required for transport-I (ESCRT-I) component TSG101 to mediate the sorting of epidermal growth factor receptor into endosomal compartments."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.576561"}], "href": "https://doi.org/10.1074/jbc.M114.576561"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25183008"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25183008"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Jing-Jing Zhang, Shuai-Bing Liu, Ling Xue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The genetic polymorphisms of POR"}, {"type": "i", "children": [{"type": "t", "text": "28 and CYP3A5"}]}, {"type": "t", "text": "3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Pharmacol Ther (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.5414/CP202152"}], "href": "https://doi.org/10.5414/CP202152"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26227094"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26227094"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Shan Deng, Kobina Essandoh, Xiaohong Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tsg101 positively regulates P62-Keap1-Nrf2 pathway to protect hearts against oxidative damage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Redox Biol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.redox.2020.101453"}], "href": "https://doi.org/10.1016/j.redox.2020.101453"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32057709"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32057709"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Nils Krone, Nicole Reisch, Jan Idkowiak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2011-0640"}], "href": "https://doi.org/10.1210/jc.2011-0640"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22162478"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22162478"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Maki Fukami, Gen Nishimura, Keiko Homma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2008-2816"}], "href": "https://doi.org/10.1210/jc.2008-2816"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19258400"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19258400"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Walter L Miller, Vishal Agrawal, Duanpen Sandee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Consequences of POR mutations and polymorphisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Endocrinol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mce.2010.10.022"}], "href": "https://doi.org/10.1016/j.mce.2010.10.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21070833"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21070833"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Fabian Z Burkhard, Shaheena Parween, Sameer S Udhane, et al. "}, {"type": "b", "children": [{"type": "t", "text": "P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Steroid Biochem Mol Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jsbmb.2016.04.003"}], "href": "https://doi.org/10.1016/j.jsbmb.2016.04.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27068427"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27068427"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Monika Linnenbaum, Mareike Busker, Jan R Kraehling, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heme oxygenase isoforms differ in their subcellular trafficking during hypoxia and are differentially modulated by cytochrome P450 reductase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0035483"}], "href": "https://doi.org/10.1371/journal.pone.0035483"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22545110"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22545110"}]}]}]}